What's happened
The Scottish government is moving to expand drug-checking services with three new centres and point-of-care testing, aiming to curb harm from contaminated drugs amid rapid changes in the illicit market. Experts say speed and wider access are essential, while concerns remain over regulatory limits and who may access services.
What's behind the headline?
Key takeaways
- The policy push follows RADAR data showing more multi-substance contamination and rising overdose risk, prompting calls for faster deployment.
- Critics warn the current model risks excluding people who use drugs who do not meet strict "dependency" criteria, potentially limiting early warning of supply changes.
- Advocates want mobile or outreach options to expand access beyond fixed sites and to younger users, to support harm reduction and timely public health responses.
What this means going forward
- If rollout is accelerated, services could provide rapid in-person verification and counselling, potentially reducing overdoses and the harm from unknown substance composition.
- Regulatory definitions and licensing timelines will strongly influence how broadly services can operate and how quickly they reach high-risk populations.
- The Dundee national lab could become a central hub for analysis, while point-of-care sites extend geographic reach across Scotland.
How we got here
Scottish ministers have backed expanding drug-checking capacity to counteract increasingly complex drug supplies. A national lab will be hosted in Dundee, with additional point-of-care services licenced in Glasgow, Aberdeen and Dundee; Edinburgh licensing is pending Home Office approval. Debates focus on eligibility rules, including an undefined term 'dependent', and age limits that may hinder broader use. Charities argue broader access is needed to preempt harms as adulteration rises.
Our analysis
The Scotsman reports that three Scottish drug-checking centres are planned with Dundee hosting the national lab; Glasgow, Aberdeen, and Dundee will have point-of-care testing licences, with Edinburgh awaiting Home Office approval. Experts including Kirsten Horsburgh and Emma Crawshaw emphasise the need for broader access and clearer definitions of dependency to enable harm reduction. The piece notes rising contamination levels, multi-substance samples, and evolving street drug risks. The Guardian and New York Times articles, while addressing different facets of drug policy and illicit drug monitoring, illustrate broader international concern over harm-reduction tools and government stances on funding and access.
Go deeper
- Should the government broaden access to drug-checking services beyond those deemed dependent on drugs?
- Will mobile testing or outreach programmes be introduced to reach younger users and those in rural areas?
- What definitions of 'dependency' will be used in practice, and how will age limits affect uptake?